Safety and efficacy of disease-modifying anti-rheumatic agents: Focus on the benefits and risks of etanercept

Roy Fleischmann, Imran Iqbal, Pallavi Nandeshwar, Andres Quiceno

Research output: Contribution to journalReview articlepeer-review

97 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of disease-modifying anti-rheumatic agents: Focus on the benefits and risks of etanercept'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds